Summary of Key Points Core Viewpoint - Baicheng Pharmaceutical (301096.SZ) announced that several board members and senior management plan to reduce their shareholdings through centralized bidding within three months after 15 trading days from the announcement date [1] Group 1: Shareholding Reduction Plans - Director and senior executive Mr. Jia Fei plans to reduce his holdings by up to 12,200 shares, representing approximately 0.0112% of the company's total share capital [1] - Director Ms. Song Bofan intends to reduce her holdings by up to 2,300 shares, which is about 0.0021% of the company's total share capital [1] - Director Mr. Yan Hongbing plans to reduce his holdings by up to 9,500 shares, accounting for approximately 0.0088% of the company's total share capital [1] - Senior executive Mr. Chen An intends to reduce his holdings by up to 11,200 shares, representing around 0.0103% of the company's total share capital [1]
百诚医药(301096.SZ)：董事、高级管理人员拟减持股份